Ioflupane I 123 Injection, Solution
Product Images NDC 69945-166

5 FDA label images from Curium Us Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Ioflupane I 123 (NDC 69945-166). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Curium Us Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Table 1 (Ioflupane I 123 1)

Table 1 (Ioflupane I 123 1)
A data table listing absorbed radiation doses per unit administered activity (µGy/MBq) for various organs and tissues, including brain, striata, GI tract components, heart, kidneys, liver, lungs, and others, as well as the effective dose per unit administered activity (µSv/MBq). The table provides detailed dosimetry information for Ioflupane I 123 injection.*
FDA Label Image

Figure 1,2,3,4 (Ioflupane I 123 2)

Figure 1,2,3,4 (Ioflupane I 123 2)
Four black and white medical imaging scans labeled as Figure 1 through Figure 4, showing brain sections with areas of higher intensity likely representing radiotracer uptake. These scans illustrate typical imaging results associated with the use of Ioflupane I 123 injection, solution, 2 mCi/mL, for intravenous administration by Curium US LLC.*
FDA Label Image

The Following Structural Formula For Ioflupane I 123 Injection Is A Sterile, Pyrogen-free Radiopharmaceutical For Intravenous Injection. The Clear And Colorless Solution Is Supplied In Single-use Vials In Which Each Milliliter Contains 0.07 To 0.13 Mcg Ioflupane, 74 Mbq (2 Mci) Of Iodine 123 (as Ioflupane I 123) At Calibration Time, 5.7 mg Acetic Acid, 7.8 mg Sodium Acetate And 0.05 mL (5%) Ethanol. (Ioflupane I 123 3)

The Following Structural Formula For Ioflupane I 123 Injection Is A Sterile, Pyrogen-free Radiopharmaceutical For Intravenous Injection. The Clear And Colorless Solution Is Supplied In Single-use Vials In Which Each Milliliter Contains 0.07 To 0.13 Mcg Ioflupane, 74 Mbq (2 Mci) Of Iodine 123 (as Ioflupane I 123) At Calibration Time, 5.7 mg Acetic Acid, 7.8 mg Sodium Acetate And 0.05 mL (5%) Ethanol. (Ioflupane I 123 3)
Chemical structure of Ioflupane I-123 depicted as a 3D molecular diagram, showing the arrangement of atoms including fluorine (F), iodine-123 (123I), and other molecular groups typical of the compound used in injection form by Curium US LLC.*
FDA Label Image

R102021 Can Label (Ioflupane I 123 4)

R102021 Can Label (Ioflupane I 123 4)
Label for Ioflupane I 123 Injection, a radiopharmaceutical injection solution with strength of 74 MBq (2 mCi) per mL and total volume of 2.5 mL, indicated for intravenous use. The single-dose vial label includes calibration date/time, expiration (7 hours post-calibration), lot number, and warns to discard unused portion. Manufactured by Curium US LLC.*
FDA Label Image

R122021 Vial Label (Ioflupane I 123 5)

R122021 Vial Label (Ioflupane I 123 5)
Label for Ioflupane I 123 Injection, a radiopharmaceutical solution for intravenous use with a concentration of 74 MBq (2 mCi) per mL and total activity of 185 MBq (5 mCi) per 2.5 mL. Supplied as a single-dose vial from Curium US LLC. The label includes calibration time and date fields, recommended dosage instructions, and a caution symbol for radioactive material.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.